Spectranetics

96 Talamine Court
Colorado Springs
CO
80909
USA
Phone: 
800-633-0960
Fax: 
719-633-2248
http://www.spectranetics.com

Related Articles

Clinical Trial/Study

Study Supports Use of Laser Atherectomy for Peripheral In-Stent Restenosis
Laser Assessed to Treat In-Stent Restenosis
Study Shows Safety, Effectiveness of Laser Assisted Lead Removal
Study Demonstrates Effectiveness of Laser Atherectomy for PAD
LExICon Study Data Shows Laser Lead Removal 97.7 Percent Effective

Peripheral Arterial Disease (PAD) Treatment Devices

Study Supports Use of Laser Atherectomy for Peripheral In-Stent Restenosis
Spectranetics Strengthens Vascular Portfolio With Purchase of Upstream Peripheral Technologies
Spectranetics Launches Tapas Catheter for Drug Delivery in Peripheral Vessels
Laser Atherectomy Allows Ease of Use in Most PAD Cases
Study Demonstrates Effectiveness of Laser Atherectomy for PAD
Spectranetics Asks FDA to Treat In-Stent Restenosis in the Legs
FDA Clears Spectranetics Turbo-Tandem Atherectomy System
Spectranetics Files Pre-IDE FDA for Treatment of In-Stent Restenosis in the Legs
Spectranetics’ New Ablation System for PAD Now Available
PAD Device Ready for U.S. Release

Cath Lab

Study Supports Use of Laser Atherectomy for Peripheral In-Stent Restenosis
Spectranetics Strengthens Vascular Portfolio With Purchase of Upstream Peripheral Technologies
Spectranetics Launches Tapas Catheter for Drug Delivery in Peripheral Vessels
An Introduction to Atherectomy Systems
Laser Assessed to Treat In-Stent Restenosis

Atherectomy Devices

Study Supports Use of Laser Atherectomy for Peripheral In-Stent Restenosis
An Introduction to Atherectomy Systems
Laser Assessed to Treat In-Stent Restenosis
Laser Atherectomy Allows Ease of Use in Most PAD Cases
Study Demonstrates Effectiveness of Laser Atherectomy for PAD
Laser Catheter Company Pays $5 Million to Resolve Allegations
Spectranetics Asks FDA to Treat In-Stent Restenosis in the Legs
FDA Clears Spectranetics Turbo-Tandem Atherectomy System
Spectranetics Files Pre-IDE FDA for Treatment of In-Stent Restenosis in the Legs
FDA Clears Spectranetics to Market TURBO-Booster

Catheter

Spectranetics Launches Tapas Catheter for Drug Delivery in Peripheral Vessels

EP Lab

Spectranetics Receives FDA Approval for Advanced GlideLight Laser Sheath
Study Shows Safety, Effectiveness of Laser Assisted Lead Removal
FDA Clears New EP Lead Removal Dilator Sheath
LExICon Study Data Shows Laser Lead Removal 97.7 Percent Effective
Spectranetics Announces First Laser Lead Extraction Procedures in Japan
Laser Ablation System Assists Removal of 975 Cardiac Leads
Laser Ablation Line Available to Treat PAD

Leads, implantable devices

Spectranetics Receives FDA Approval for Advanced GlideLight Laser Sheath
Advances in Transvenous Lead Extraction
Simulation Trains for Laser Lead Extractions
Study Shows Safety, Effectiveness of Laser Assisted Lead Removal
FDA Clears New EP Lead Removal Dilator Sheath
LExICon Study Data Shows Laser Lead Removal 97.7 Percent Effective
Strategies, New Technologies Aid Lead Management
Spectranetics Announces First Laser Lead Extraction Procedures in Japan
Laser Ablation Line Available to Treat PAD

Cardiac Rhythm Management Therapy

Advances in Transvenous Lead Extraction
Simulation Trains for Laser Lead Extractions
Spectranetics Announces First Laser Lead Extraction Procedures in Japan

Vena Cava Filters

Advances in Transvenous Lead Extraction

Ablation Systems

Laser Assessed to Treat In-Stent Restenosis
Laser Catheter Company Pays $5 Million to Resolve Allegations
Spectranetics Asks FDA to Treat In-Stent Restenosis in the Legs
Spectranetics Files Pre-IDE FDA for Treatment of In-Stent Restenosis in the Legs
Laser Ablation System Assists Removal of 975 Cardiac Leads
Spectranetics Surpasses Endpoint for PAD in CELLO Trial

Simulators

Simulation Trains for Laser Lead Extractions

Education/Training

Simulation Trains for Laser Lead Extractions

Stents

Spectranetics Files Pre-IDE FDA for Treatment of In-Stent Restenosis in the Legs

Catheters

Spectranetics Files Pre-IDE FDA for Treatment of In-Stent Restenosis in the Legs
Spectranetics Cross-Pilot Laser Support Catheter Receives FDA Clearance
FDA Clears Spectranetics to Market TURBO-Booster
Tapas catheter

Cardiology Products

Strategies, New Technologies Aid Lead Management
LLD EZ Designed to Remove Infected Cardiac Leads
Spectranetics Announces First Laser Lead Extraction Procedures in Japan
Laser Ablation System Assists Removal of 975 Cardiac Leads

General Cardiology

Strategies, New Technologies Aid Lead Management
Spectranetics Announces First Laser Lead Extraction Procedures in Japan
Laser Ablation System Assists Removal of 975 Cardiac Leads

Pacemakers

Spectranetics Announces First Laser Lead Extraction Procedures in Japan

Implantable Cardioverter Defibrillators (ICD)

Spectranetics Announces First Laser Lead Extraction Procedures in Japan

Defibrillator Monitors

Lead-Lock Designed for Secure Lead Removal